meglumine has been researched along with Kidney Diseases in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 16 (66.67) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, W; El-Bulbul, J; Goldberg, A; Jawahar, A; Joyce, C; Yacoub, J | 1 |
| Dewey, M; Schönenberger, E | 1 |
| Buemi, M; Lacquaniti, A | 1 |
| Azzouz, M; Rømsing, J; Thomsen, HS | 1 |
| Alves, MP; Daher, EF; Henn, GA; Martins, AM; Meneses, GC; Montenegro, BL; Oliveira, MJ; Rocha, HA; Sampaio, AM; Silva, GB | 1 |
| Cerón, JJ; Garcia-Martinez, JD; Martínez-Subiela, S; Pardo-Marín, L; Pastor, J; Segarra, S; Tvarijonaviciute, A | 1 |
| Feuerlein, S; Juchems, MS; Possekel, AK | 1 |
| Aresu, L; Bianciardi, P; Brovida, C; Castagnaro, M; Cavicchioli, L; Giroud, L; Valente, M; Vischer, C | 1 |
| Chrysochou, C; Husain, S; Kalra, PA; Lay, J; Moser, S; Power, A; Salama, AD; Shurrab, AE | 1 |
| Cha, SW; Kim, H; Kim, KW; Kim, MJ; Lim, JS; Park, MS; Yoo, HS | 1 |
| Abreu, KL; Daher, EF; Franco, LF; Garcia, AV; Libório, AB; Mota, RM; Oliveira, MJ; Rocha, NA; Silva Júnior, GB | 1 |
| Boll, DT; Chea, YW; Dale, BM; Merkle, EM; Neville, AM; Samei, E; Wang, CL | 1 |
| Attenberger, UI; Michaely, HJ; Reiser, MF; Schoenberg, SO; Sourbron, SP | 1 |
| de Campos, RO; De Toni, MS; Fuller, ER; Heredia, V; Lugo-Somolinos, A; Ramalho, M; Semelka, RC | 1 |
| Glockner, JF; Mostardi, PM; Riederer, SJ; Young, PM | 1 |
| Andrade, LC; Daher, EF; Junior, GB; Libório, AB; Lima, CG; Martins, AM; Mota, RM; Oliveira, RA; Sanches, TR; Seguro, AC | 1 |
| Bhalla, AS; Gamanagatti, S; Goyal, A; Seth, A; Sharma, R | 1 |
| Aloisi, C; Arena, A; Baldari, S; Buemi, F; Buemi, M; Giardina, C; Lacquaniti, A; Lupica, R; Murè, G; Visalli, C | 1 |
| de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP | 1 |
| Attenberger, UI; Glaser, CG; Lodemann, KP; Michaely, HJ; Notohamiprodjo, M; Reiser, MF; Schoenberg, SO; Sourbron, SP | 1 |
| Marsden, PD; Sampaio, RN; Veiga, JP; Wolff, ER | 1 |
| Ascher, SM; Brown, JJ; Colindres, RE; Corrigan, K; Semelka, RC | 1 |
| Bernreuter, WK; Kenney, PJ; Listinsky, JJ; Morgan, DE; Rominger, MB | 1 |
| Almès, C; Bruel, JM; Lamarque, JL; Lopez, P; Martin, JM; Prat, X; Pujol, J; Rodière, MJ; Rossi, M; Rouanet, JP | 1 |
2 trial(s) available for meglumine and Kidney Diseases
| Article | Year |
|---|---|
Fluctuations in eGFR in relation to unenhanced and enhanced MRI and CT outpatients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Artifacts; Contrast Media; Denmark; Female; Glomerular Filtration Rate; Humans; Incidence; Iopamidol; Kidney Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Creatinine; Diagnostic Imaging; Enzyme-Linked Immunosorbent Assay; Female; Gelatinases; Glomerular Filtration Rate; Humans; Iopamidol; Kidney Diseases; Lipocalins; Male; Meglumine; Middle Aged; Organometallic Compounds; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Sodium Bicarbonate; Sodium Chloride | 2013 |
22 other study(ies) available for meglumine and Kidney Diseases
| Article | Year |
|---|---|
Safety profile of Gadoterate meglumine on the renal function of patients with severe kidney disease.
Topics: Contrast Media; Gadolinium; Humans; Kidney; Kidney Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2022 |
Increase in creatinine for the prediction of contrast-induced nephropathy.
Topics: Diagnostic Imaging; Female; Humans; Iopamidol; Kidney Diseases; Lipocalins; Male; Meglumine; Organometallic Compounds; Radiopharmaceuticals | 2013 |
Response.
Topics: Diagnostic Imaging; Female; Humans; Iopamidol; Kidney Diseases; Lipocalins; Male; Meglumine; Organometallic Compounds; Radiopharmaceuticals | 2013 |
Preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with visceral leishmaniasis.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Chemokine CCL2; Female; Humans; Inflammation; Kidney; Kidney Diseases; Leishmaniasis, Visceral; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2014 |
Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment.
Topics: Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Drug Therapy, Combination; Kidney Diseases; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteinuria | 2017 |
[Rosai-Dorfman disease with bilateral kidney involvement: morphologic image characteristics of a very rare organ manifestation].
Topics: Adult; Biopsy, Needle; Contrast Media; Diffusion Magnetic Resonance Imaging; Histiocytosis, Sinus; Humans; Image Enhancement; Image Processing, Computer-Assisted; Kidney Calices; Kidney Diseases; Lymph Nodes; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Radiology, Interventional; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.
Topics: Animals; Antiprotozoal Agents; Body Weight; Dogs; Female; Fluorescent Antibody Technique; Histocytochemistry; Kidney; Kidney Diseases; Kidney Tubules; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Microscopy, Electron; Organometallic Compounds; Phosphorylcholine; Random Allocation; Toxicity Tests | 2009 |
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors | 2010 |
Potential conditions causing impairment of selective hepatobiliary enhancement of gadobenate dimeglumine-enhanced delayed magnetic resonance imaging.
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Biliary Tract; Bilirubin; Blood Urea Nitrogen; Contrast Media; Creatinine; Female; Humans; Image Enhancement; Kidney Diseases; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Retrospective Studies; Splenomegaly | 2010 |
Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Kidney Diseases; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Young Adult | 2010 |
Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T.
Topics: Adult; Analysis of Variance; Contrast Media; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Female; Gadolinium DTPA; Humans; Kidney Diseases; Liver Diseases; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Diseases; Retrospective Studies; Splenic Diseases | 2011 |
Retrospective respiratory triggering renal perfusion MRI.
Topics: Artifacts; Contrast Media; Feasibility Studies; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Kidney; Kidney Diseases; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Respiration; Retrospective Studies | 2010 |
Quarter-dose (0.025 mmol/kg) gadobenate dimeglumine for abdominal MRI in patients at risk for nephrogenic systemic fibrosis: preliminary observations.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Feasibility Studies; Female; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pregnancy; Retrospective Studies; Risk Factors; Statistics, Nonparametric | 2011 |
Contrast-enhanced MR angiography of the abdomen with highly accelerated acquisition techniques.
Topics: Adult; Aged; Case-Control Studies; Contrast Media; Female; Humans; Image Enhancement; Imaging, Three-Dimensional; Kidney Diseases; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Circulation | 2011 |
Renal function evaluation in patients with American cutaneous leishmaniasis after specific treatment with pentavalent antimonial.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Kidney; Kidney Diseases; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Diffusion-weighted MRI in inflammatory renal lesions: all that glitters is not RCC!
Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Inflammation; Kidney Diseases; Kidney Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Diseases; Kidney Function Tests; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2008 |
MR-based semi-automated quantification of renal functional parameters with a two-compartment model--an interobserver analysis.
Topics: Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Kidney Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Prospective Studies; Renal Circulation | 2008 |
Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Gluconates; Humans; Kidney Diseases; Kidney Tubules; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1983 |
Renal corticomedullary differentiation: observation in patients with differing serum creatinine levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Creatinine; Drug Combinations; Female; Gadolinium DTPA; Humans; Kidney Cortex; Kidney Diseases; Kidney Medulla; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1994 |
Gadolinium-enhanced MR imaging of renal masses.
Topics: Carcinoma, Renal Cell; Contrast Media; Cysts; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Kidney Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid | 1992 |
Ideal imaging in MR: contrast-enhancing pharmaceuticals. Evaluation of tempo carboxylic acid as nitroxide diagnostic agent.
Topics: Animals; Cyclic N-Oxides; Kidney; Kidney Diseases; Magnetic Resonance Spectroscopy; Male; Meglumine; Rats; Rats, Inbred Strains; Spin Labels; Urinary Bladder | 1986 |